Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.

1,962 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. (2014, background): “The lifetime risk of developing AF for individuals 40 to 55 years of age has been estimated to be 22% to 26%.(4,9) It is important to note that the above-cited epidemiological studies likely underestimate the true disease burden.”
Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. (2014, background): “Atrial fibrillation (AF) is a major cause of cardiovascular morbidity and mortality (1).”
The Rotterdam Study: 2010 objectives and design update (2007, background): “and lifetime risk of heart failure and atrial fibrillation in an elderly population [33, 34].”
Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. (2013, background): “2 in those aged 85 years and older, respectively) [35,39].”
Underuse of oral anticoagulants in atrial fibrillation: a systematic review. (2010, background): “1 per 1000 person-years,(2-4) and ncreases substantially with age.(2,5) Atrial fibrillation paients are at higher risk of stroke, and cardiovascular- and”
Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium (2013, neutral): “Age, y 60 (8) 73 (5) 73 (5) 63 (6) 62 (6) 76 (6) 72 (7)”